[Behavior of the salivary electrolytes potassium and calcium in digitalized patients following administration of diphenylhydantoin].
D000112:Acetyldigitoxins / Q000009:adverse effects / Q000627:therapeutic use*; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy; D002118:Calcium / Q000378:metabolism*; D004074:Digitoxin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D010672:Phenytoin / Q000627:therapeutic use*; D010770:Phosphotransferases / Q000037:antagonists & inhibitors / Q000494:pharmacology; D011188:Potassium / Q000378:metabolism*; D012463:Saliva / Q000378:metabolism*
D000112:Acetyldigitoxins; D010672:Phenytoin; D004074:Digitoxin; D010770:Phosphotransferases; D011188:Potassium; D002118:Calcium
Verhalten der Speichelelektrolyte Kalium und Kalzium bei digitalisierten Patienten nach Gabe von Diphenylhydantoin